nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.502	1	CbGbCtD
Estropipate—Uterine leiomyoma—Riluzole—amyotrophic lateral sclerosis	0.0209	0.0563	CcSEcCtD
Estropipate—Uterine haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0421	CcSEcCtD
Estropipate—Dementia—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0358	CcSEcCtD
Estropipate—Vaginal moniliasis—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0291	CcSEcCtD
Estropipate—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0279	CcSEcCtD
Estropipate—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.00998	0.0269	CcSEcCtD
Estropipate—Polyp—Riluzole—amyotrophic lateral sclerosis	0.00896	0.0242	CcSEcCtD
Estropipate—Embolism—Riluzole—amyotrophic lateral sclerosis	0.0085	0.0229	CcSEcCtD
Estropipate—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00816	0.022	CcSEcCtD
Estropipate—SHBG—hindlimb—amyotrophic lateral sclerosis	0.00803	0.204	CbGeAlD
Estropipate—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.00785	0.0211	CcSEcCtD
Estropipate—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00771	0.0208	CcSEcCtD
Estropipate—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00764	0.0206	CcSEcCtD
Estropipate—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0073	0.0197	CcSEcCtD
Estropipate—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00625	0.0168	CcSEcCtD
Estropipate—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00621	0.0167	CcSEcCtD
Estropipate—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00616	0.0166	CcSEcCtD
Estropipate—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00604	0.0163	CcSEcCtD
Estropipate—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00596	0.0161	CcSEcCtD
Estropipate—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00545	0.0147	CcSEcCtD
Estropipate—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00518	0.0139	CcSEcCtD
Estropipate—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00501	0.0135	CcSEcCtD
Estropipate—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00493	0.0133	CcSEcCtD
Estropipate—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00478	0.0129	CcSEcCtD
Estropipate—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00453	0.0122	CcSEcCtD
Estropipate—Injury—Riluzole—amyotrophic lateral sclerosis	0.00431	0.0116	CcSEcCtD
Estropipate—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00411	0.0111	CcSEcCtD
Estropipate—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00409	0.011	CcSEcCtD
Estropipate—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0039	0.0105	CcSEcCtD
Estropipate—ESR2—hindbrain—amyotrophic lateral sclerosis	0.00376	0.0955	CbGeAlD
Estropipate—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00375	0.0101	CcSEcCtD
Estropipate—SHBG—hindbrain—amyotrophic lateral sclerosis	0.00366	0.0928	CbGeAlD
Estropipate—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00358	0.00964	CcSEcCtD
Estropipate—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00928	CcSEcCtD
Estropipate—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00922	CcSEcCtD
Estropipate—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00922	CcSEcCtD
Estropipate—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00904	CcSEcCtD
Estropipate—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00884	CcSEcCtD
Estropipate—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00862	CcSEcCtD
Estropipate—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00839	CcSEcCtD
Estropipate—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00822	CcSEcCtD
Estropipate—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00822	CcSEcCtD
Estropipate—Depression—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0082	CcSEcCtD
Estropipate—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0081	CcSEcCtD
Estropipate—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00806	CcSEcCtD
Estropipate—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00806	CcSEcCtD
Estropipate—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00777	CcSEcCtD
Estropipate—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00771	CcSEcCtD
Estropipate—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00275	0.0074	CcSEcCtD
Estropipate—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00732	CcSEcCtD
Estropipate—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00727	CcSEcCtD
Estropipate—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00698	CcSEcCtD
Estropipate—ESR1—hindbrain—amyotrophic lateral sclerosis	0.00258	0.0654	CbGeAlD
Estropipate—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00256	0.0069	CcSEcCtD
Estropipate—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00685	CcSEcCtD
Estropipate—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00669	CcSEcCtD
Estropipate—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00666	CcSEcCtD
Estropipate—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00665	CcSEcCtD
Estropipate—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00652	CcSEcCtD
Estropipate—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00646	CcSEcCtD
Estropipate—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00642	CcSEcCtD
Estropipate—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00633	CcSEcCtD
Estropipate—Tension—Riluzole—amyotrophic lateral sclerosis	0.00234	0.0063	CcSEcCtD
Estropipate—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00624	CcSEcCtD
Estropipate—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00621	CcSEcCtD
Estropipate—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00618	CcSEcCtD
Estropipate—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00587	CcSEcCtD
Estropipate—ESR2—brainstem—amyotrophic lateral sclerosis	0.00216	0.0547	CbGeAlD
Estropipate—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00577	CcSEcCtD
Estropipate—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00568	CcSEcCtD
Estropipate—SHBG—brainstem—amyotrophic lateral sclerosis	0.0021	0.0532	CbGeAlD
Estropipate—Cough—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00561	CcSEcCtD
Estropipate—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00547	CcSEcCtD
Estropipate—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00547	CcSEcCtD
Estropipate—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00545	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00543	CcSEcCtD
Estropipate—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00524	CcSEcCtD
Estropipate—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00524	CcSEcCtD
Estropipate—Infection—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00521	CcSEcCtD
Estropipate—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00514	CcSEcCtD
Estropipate—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00509	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00478	CcSEcCtD
Estropipate—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00474	CcSEcCtD
Estropipate—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00471	CcSEcCtD
Estropipate—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00466	CcSEcCtD
Estropipate—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00461	CcSEcCtD
Estropipate—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00453	CcSEcCtD
Estropipate—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00452	CcSEcCtD
Estropipate—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00448	CcSEcCtD
Estropipate—Pain—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00448	CcSEcCtD
Estropipate—ESR1—embryo—amyotrophic lateral sclerosis	0.00161	0.0409	CbGeAlD
Estropipate—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00429	CcSEcCtD
Estropipate—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00416	CcSEcCtD
Estropipate—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00414	CcSEcCtD
Estropipate—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00414	CcSEcCtD
Estropipate—ESR1—brainstem—amyotrophic lateral sclerosis	0.00148	0.0375	CbGeAlD
Estropipate—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00386	CcSEcCtD
Estropipate—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00376	CcSEcCtD
Estropipate—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00371	CcSEcCtD
Estropipate—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00359	CcSEcCtD
Estropipate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00347	CcSEcCtD
Estropipate—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00333	CcSEcCtD
Estropipate—Rash—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00331	CcSEcCtD
Estropipate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0033	CcSEcCtD
Estropipate—Headache—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00328	CcSEcCtD
Estropipate—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00311	CcSEcCtD
Estropipate—ESR2—nervous system—amyotrophic lateral sclerosis	0.00113	0.0287	CbGeAlD
Estropipate—ESR2—central nervous system—amyotrophic lateral sclerosis	0.00109	0.0276	CbGeAlD
Estropipate—ESR2—cerebellum—amyotrophic lateral sclerosis	0.00106	0.027	CbGeAlD
Estropipate—SHBG—central nervous system—amyotrophic lateral sclerosis	0.00106	0.0268	CbGeAlD
Estropipate—SHBG—cerebellum—amyotrophic lateral sclerosis	0.00103	0.0262	CbGeAlD
Estropipate—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.000947	0.024	CbGeAlD
Estropipate—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.000912	0.0231	CbGeAlD
Estropipate—ESR2—brain—amyotrophic lateral sclerosis	0.000863	0.0219	CbGeAlD
Estropipate—SHBG—brain—amyotrophic lateral sclerosis	0.000839	0.0213	CbGeAlD
Estropipate—ESR1—nervous system—amyotrophic lateral sclerosis	0.000773	0.0196	CbGeAlD
Estropipate—ESR1—central nervous system—amyotrophic lateral sclerosis	0.000745	0.0189	CbGeAlD
Estropipate—ESR1—cerebellum—amyotrophic lateral sclerosis	0.000728	0.0185	CbGeAlD
Estropipate—SLC22A1—brain—amyotrophic lateral sclerosis	0.000724	0.0184	CbGeAlD
Estropipate—ALB—brain—amyotrophic lateral sclerosis	0.000693	0.0176	CbGeAlD
Estropipate—ESR1—brain—amyotrophic lateral sclerosis	0.000591	0.015	CbGeAlD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.000556	0.00635	CbGpPWpGaD
Estropipate—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000527	0.00602	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.000525	0.006	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000521	0.00595	CbGpPWpGaD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—amyotrophic lateral sclerosis	0.000503	0.00575	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.000501	0.00572	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000488	0.00558	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000482	0.0055	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000475	0.00542	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000464	0.0053	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.000462	0.00528	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000459	0.00525	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000456	0.0052	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—IGF1—amyotrophic lateral sclerosis	0.000438	0.005	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000437	0.00499	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000435	0.00497	CbGpPWpGaD
Estropipate—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000432	0.011	CbGeAlD
Estropipate—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000415	0.0105	CbGeAlD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—amyotrophic lateral sclerosis	0.000412	0.00471	CbGpPWpGaD
Estropipate—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000411	0.00469	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000404	0.00461	CbGpPWpGaD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—C3—amyotrophic lateral sclerosis	0.000399	0.00455	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000391	0.00446	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00039	0.00445	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000373	0.00426	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.000364	0.00416	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000356	0.00407	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000335	0.00383	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000331	0.00379	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000331	0.00379	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000331	0.00378	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000331	0.00378	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000321	0.00367	CbGpPWpGaD
Estropipate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.00032	0.00366	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—MMP9—amyotrophic lateral sclerosis	0.000319	0.00364	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000316	0.00361	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000309	0.00353	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000303	0.00346	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000302	0.00344	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000299	0.00341	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000296	0.00339	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.000296	0.00338	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000295	0.00337	CbGpPWpGaD
Estropipate—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000295	0.00337	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000289	0.00331	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000282	0.00322	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.000281	0.00321	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—FUS—amyotrophic lateral sclerosis	0.00028	0.0032	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000273	0.00312	CbGpPWpGaD
Estropipate—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000273	0.00312	CbGpPWpGaD
Estropipate—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000272	0.0031	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000271	0.0031	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000269	0.00307	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000269	0.00307	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000261	0.00298	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000259	0.00296	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000254	0.0029	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000254	0.0029	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000254	0.0029	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000254	0.0029	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000249	0.00285	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000246	0.00281	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000246	0.00281	CbGpPWpGaD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.000245	0.0028	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000242	0.00276	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.00024	0.00274	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000239	0.00274	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000239	0.00273	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000235	0.00269	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000234	0.00267	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000233	0.00266	CbGpPWpGaD
Estropipate—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000232	0.00265	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000231	0.00264	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00023	0.00262	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000229	0.00261	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000226	0.00259	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000219	0.00251	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000212	0.00242	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000211	0.00241	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.00021	0.0024	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00021	0.0024	CbGpPWpGaD
Estropipate—ESR1—LKB1 signaling events—TP53—amyotrophic lateral sclerosis	0.000208	0.00238	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	0.000208	0.00237	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000197	0.00225	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000197	0.00225	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000195	0.00223	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000195	0.00223	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000193	0.0022	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000189	0.00216	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000188	0.00215	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000185	0.00211	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00018	0.00205	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000173	0.00198	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000167	0.0019	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000166	0.00189	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000162	0.00185	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000162	0.00185	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000161	0.00184	CbGpPWpGaD
Estropipate—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000161	0.00184	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000161	0.00183	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00016	0.00183	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000155	0.00177	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000154	0.00176	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000154	0.00176	CbGpPWpGaD
Estropipate—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000153	0.00175	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000152	0.00174	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000151	0.00173	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000148	0.00169	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000148	0.00169	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000141	0.00161	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	0.000141	0.00161	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000141	0.00161	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.00014	0.0016	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000138	0.00157	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000137	0.00156	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000137	0.00156	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000137	0.00156	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000133	0.00152	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000131	0.0015	CbGpPWpGaD
Estropipate—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000131	0.0015	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000129	0.00148	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000128	0.00146	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000127	0.00145	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000125	0.00143	CbGpPWpGaD
Estropipate—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000124	0.00142	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000123	0.00141	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000122	0.00139	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00012	0.00137	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000119	0.00136	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000119	0.00136	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000115	0.00132	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000113	0.00129	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000111	0.00127	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.00011	0.00126	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00011	0.00126	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000109	0.00124	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000107	0.00123	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000106	0.00121	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000104	0.00118	CbGpPWpGaD
Estropipate—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000103	0.00118	CbGpPWpGaD
Estropipate—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000103	0.00118	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000101	0.00116	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000101	0.00115	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000101	0.00115	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	9.84e-05	0.00112	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	9.64e-05	0.0011	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.6e-05	0.0011	CbGpPWpGaD
Estropipate—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	9.42e-05	0.00108	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.4e-05	0.00107	CbGpPWpGaD
Estropipate—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.27e-05	0.00106	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	9.13e-05	0.00104	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	9.13e-05	0.00104	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	8.92e-05	0.00102	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	8.86e-05	0.00101	CbGpPWpGaD
Estropipate—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.76e-05	0.001	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.44e-05	0.000964	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	8.43e-05	0.000963	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	8.43e-05	0.000963	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	8.35e-05	0.000954	CbGpPWpGaD
Estropipate—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	8.23e-05	0.000941	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.14e-05	0.00093	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.86e-05	0.000898	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	7.81e-05	0.000893	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	7.79e-05	0.000889	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	7.71e-05	0.000881	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	7.62e-05	0.00087	CbGpPWpGaD
Estropipate—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	7.45e-05	0.000851	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.35e-05	0.000839	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.26e-05	0.000829	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	7.2e-05	0.000823	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	7.2e-05	0.000823	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.17e-05	0.000819	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.16e-05	0.000818	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	6.96e-05	0.000796	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	6.87e-05	0.000785	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	6.75e-05	0.000771	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	6.74e-05	0.00077	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.72e-05	0.000767	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	6.59e-05	0.000753	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.39e-05	0.00073	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.31e-05	0.000721	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.13e-05	0.0007	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	6.1e-05	0.000696	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.99e-05	0.000684	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.92e-05	0.000677	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	5.81e-05	0.000664	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	5.76e-05	0.000658	CbGpPWpGaD
Estropipate—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	5.64e-05	0.000645	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	5.56e-05	0.000635	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	5.56e-05	0.000635	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	5.21e-05	0.000595	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	5.21e-05	0.000595	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	5.21e-05	0.000595	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	5.09e-05	0.000581	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.74e-05	0.000542	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.73e-05	0.00054	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	4.62e-05	0.000528	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	4.49e-05	0.000513	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	4.44e-05	0.000508	CbGpPWpGaD
Estropipate—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	4.28e-05	0.000489	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	4.26e-05	0.000487	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.07e-05	0.000465	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	4.02e-05	0.000459	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.95e-05	0.000451	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.9e-05	0.000446	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.88e-05	0.000444	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.82e-05	0.000436	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	3.64e-05	0.000416	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.63e-05	0.000415	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.54e-05	0.000405	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	3.5e-05	0.0004	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.44e-05	0.000393	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.32e-05	0.000379	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.19e-05	0.000365	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.16e-05	0.000361	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.11e-05	0.000355	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.05e-05	0.000348	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.99e-05	0.000342	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.92e-05	0.000334	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.81e-05	0.000321	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.73e-05	0.000312	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.67e-05	0.000305	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	2.6e-05	0.000297	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.58e-05	0.000295	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.41e-05	0.000275	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.31e-05	0.000264	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.31e-05	0.000264	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.3e-05	0.000263	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.19e-05	0.00025	CbGpPWpGaD
Estropipate—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.11e-05	0.000241	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.99e-05	0.000227	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.88e-05	0.000215	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.87e-05	0.000214	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.78e-05	0.000203	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.75e-05	0.0002	CbGpPWpGaD
Estropipate—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.74e-05	0.000199	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.73e-05	0.000198	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.61e-05	0.000184	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.53e-05	0.000175	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.48e-05	0.000169	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.45e-05	0.000165	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.42e-05	0.000163	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.3e-05	0.000148	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.24e-05	0.000142	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.22e-05	0.000139	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.19e-05	0.000136	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.14e-05	0.00013	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.81e-06	0.000112	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.75e-06	0.000111	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	9.38e-06	0.000107	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.33e-06	9.52e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.43e-06	7.34e-05	CbGpPWpGaD
